argenx
ARGENX B.V.
Süreç
- Başvuru 10 Mart 2025
- Bültende yayın Resmî Marka Bülteni 471 · 27 Haziran 2025
- İtiraz penceresi (2 ay) Son gün 27 Ağustos 2025 · kapandı
- Tescil Tescil no 2025 077957· Gazete 498 (28 Kasım 2025)
- Yenileme Koruma 10 yıl: yenileme tarihi Mart 2035 (son 6 ay içinde başvurulur).
Resmî süreler ve işlemler için TÜRKPATENT esastır; Nomist bilgilendirme aracıdır.
Sınıflar ve kapsam
Mal ve hizmet listesi
Pharmaceuticals and medical preparations for therapeutic purposes in the field of immunology and autoimmune diseases; pharmaceutical preparations for the prevention or treatment of autoimmune, antibody -mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, and transplantation-related diseases and disorders, cancer and diseases of the immune system; compositions of antibodies or fragments of antibodies or derivatives of antibodies with therapeutic properties; antibodies or fragments of antibodies or derivatives of antibodies for the prevention or treatment of autoimmune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, transplantation-related diseases and disorders, cancer and diseases of the immune system.Wholesale and retail services for therapeutic pharmaceutical preparations in the field of immunology and auto-immune diseases and antibodies or fragments or derivatives of antibodies with therapeutic properties; administrative services in relation to patient information in the field of immunology, diseases of the immune system and antibody therapeutics; administration of patient reimbursement programs.Research and development in the field of immunology, antibody engineering and autoimmune diseases for therapeutic purposes; therapeutic drug research and development in the field of immunology, antibody technology and autoimmune diseases; scientific and technological services and research relating to immunity, autoimmune diseases and antibody engineering for therapeutic purposes; providing medical and scientific research information in the field of therapeutic pharmaceuticals, clinical trials, research and development.Providing information to patients in the field of auto-immune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, and transplantation-related diseases and disorders, cancer and diseases of the immune system and the treatment thereof; consultancy and information services relating to therapeutic biopharmaceutical products; provision of information on therapeutic pharmaceutical, medical, and healthcare products to customers or patients through an online computer network.
Aynı bültende benzer başvurular
Bülten 471 içindeki 4.178 aynı-sınıf başvuru arasında Nomist'in benzerlik algoritmasına takılan yok.